Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 4, 2022

New Data for Genentech’s Ocrevus (Ocrelizumab) Show Benefit in Disability Progression and Cognitive Decline in Both Secondary Progressive and Primary Progressive Multiple Sclerosis

  • MS Drug Therapies
    /
  • Ocrevus
    /
  75% of patients with secondary progressive multiple sclerosis (SPMS) and primary progressive MS (PPMS) achieved no evidence of progression…
MS Drug Therapies

March 30, 2022

Latest updates for diagnosis and management of NMOSD

  • NMO (NMOSD/Devics)
    /
  In this enduring touchSATELLITE SYMPOSIUM (#ACTRIMS22), Prof. Sean Pittock, Dr Amy Kunchok, and Prof. Dean Wingerchuk share their insights…
NMO (NMOSD/Devics)

March 29, 2022

About BAFIERTAM™ (monomethyl fumarate) treatment, for Multiple Sclerosis

  • MS Drug Therapies
    /
Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis, is available in the…
MS Drug Therapies

March 29, 2022

Survey Alert: What Health Issues are the Highest Research Priorities for Women Living with MS?

  • Misc. MS Related
    /
 March 29, 2022 Recent research pinpointed significant knowledge gaps in the extent to which women’s health issues have been studied…
Misc. MS Related

March 22, 2022

Myelin Repair, Progressive MS, Exercise, and Other Research News

  • MRI
    /
  • MS Diet & Nutrition
    /
  • MS Genetic Research
    /
  • Multiple Sclerosis
    /
  • Myelin Repair
    /
  • National MS Society Related
    /
 October 22, 2021 Myelin repair strategies, progressive MS, exercise, and other promising avenues took center stage at the virtual European…
MRI

March 18, 2022

3D Showing of Mayzent Binding to Receptor Could Advance Treatments

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 by Steve Bryson PhD | March 18, 2022 For the first time, researchers have brought to light the precise three-dimensional structure of Mayzent (siponimod) as…
MS Drug Therapies

March 18, 2022

Immune Reaction to Milk Protein May Explain Dairy’s Link to MS

  • MS Research Study and Reports
    /
  Immune system reaction to casein, a protein in cow’s milk, can trigger an inflammatory neurological disease in mice that’s…
MS Research Study and Reports

March 18, 2022

PIPE-307, Aiming to Restore Myelin, Found Safe in Phase 1 Trial

  • MS Research Study and Reports
    /
  • Myelin Repair
    /
PIPE-307, an investigational myelin-restoring medication being developed by Pipeline Therapeutics for the treatment of multiple sclerosis (MS), appears to be…
MS Research Study and Reports

March 16, 2022

An MS Educational Skit (with MS Neuros Thrower & Boster), that will Help You Learn about The Immune System and Multiple Sclerosis

  • Diversity & Inclusion
    /
  • Facts of MS
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Multiple Sclerosis Videos
    /
  * – Watch https://youtu.be/Xcva0swapuM as Dr. Ben Thrower plays “Multiple Sclerosis (MS)” (the Invader) and Dr. Aaron Boster plays…
Diversity & Inclusion

March 13, 2022

Serum GFA Identified as a Biomarker for NMOSD, sNfL as a Predictor of Poor Post-Attack Outcomes

  • NMO (NMOSD/Devics)
    /
  • Other Neuro Conditions
    /
 March 12, 2022 A systematic literature review of randomized controlled trials in neuromyelitis optica spectrum disorder was performed, with 7…
NMO (NMOSD/Devics)

Categories

Latest Blog Posts